While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

Jan. 20, 2025, marks five years since the CDC reported the first laboratory-confirmed case of COVID-19 on American soil.

An executive order is in the works that would halt U.S. funding for research that makes viruses that are more virulent or ...

Under the new guidelines, applicants are no longer required to submit proof of COVID-19 vaccination on Form I-693 ...

On Jan. 23, 2020, the Chinese government issued a travel ban for all residents of Wuhan, the epicenter of a novel coronavirus ...

Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining ...

Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats ...

A big step forward in COVID-19 treatment and a breakthrough for a Florida-based nonprofit blood center serving the southeast. OneBlood just became the first blood center to get full FDA approval to ...

USF public health professor Donna Petersen says collaboration was critical in helping community leaders respond to the ...

Pulmonary fibrosis in patients with COVID-19 tends to resolve, while idiopathic pulmonary fibrosis always progresses.